Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 223

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 15
Chunk 223
---
 remediation plan, during the year
ended October 31, 2024, we have implemented remediation efforts including independent review and approval of transactions and reconciliations
in some processes by hiring personnel and segregating duties amongst the team. Management is also implementing processes to document
and retain evidence to support reviews and reconciliations. We also engaged outside consultants, experts in the controls and procedures
over financial reporting, and internally, we continue to review and improve these processes.

(c) Attestation Report of the Registered Public Accounting
Firm

This Annual Report on Form 20-F does not include
an attestation report of our independent registered public accounting firm regarding internal control over financial reporting due to
an exemption for emerging growth companies provided in the JOBS Act.

(d) Changes in Internal Control over Financial Reporting

During the year ended October 31, 2024, we have
implemented measures to remediate identified material weaknesses, as described above. Other than such measures, there were no changes
in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.

ITEM 16. [RESERVED]